# Clear Guide Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/clear-guide-medical

- Industry: Medical Devices & Equipment
- Headquarters: Baltimore, US
- Website: www.clearguidemedical.com
- Total disclosed funding: $3M
- Latest round: Series A (Apr 21, 2016)
- Investors on record: 1

## About

Clear Guide Medical, LLC offers advanced imaging solutions that enhance precision in ultrasound-guided procedures, focusing on improving success rates for medical professionals during critical interventions.Established in 2010, Clear Guide Medical specializes in imaging technologies for ultrasound-guided procedures. The company has not undergone significant pivots and operates independently. It is headquartered in Baltimore, US, and was founded by a team with relevant backgrounds in medical technology. The company has completed a total of 3 deals, with the most recent funding round occurring on July 9, 2018. During this round, it received a USD 2 million GRANT from the National Institutes of Health, contributing to a total of USD 3 million raised.Clear Guide Medical specializes in advanced imaging solutions designed to enhance the precision and effectiveness of ultrasound-guided procedures. Their core product offerings include Clear Guide SCENERGY, an AI-driven instrument recognition and targeting system, and the Scenergy-TP™, which facilitates various procedural applications. These technologies aim to address critical challenges in reaching pediatric targets during procedures, significantly increasing the likelihood of success on the first attempt. The company's products are primarily utilized in clinical settings, catering to healthcare providers, including hospitals and medical training institutions. The end users typically include medical professionals, particularly in specialties relying on ultrasound for invasive procedures. Clear Guide Medical's products are marketed primarily in North America and select international markets, targeting regions with advanced healthcare infrastructure.Clear Guide Medical generates revenue through the sale of its imaging solutions, including proprietary technologies like the Clear Guide SCENERGY and Scenergy-TP™. Business transactions typically occur through direct sales to healthcare institutions, where clients purchase these products for in-house use or medical training programs. The company may also engage in partnerships to facilitate broader distribution and educational outreach. Pricing structures include one-time purchases or potential subscription models for ongoing support and updates, aligning with industry practices for medical technology providers. Specific pricing details for individual products or services are not disclosed, but the overall revenue model capitalizes on the growing demand for sophisticated imaging solutions in the medical field.Clear Guide Medical plans to utilize the USD 2 million GRANT funding from July 2018 to support the development of new imaging products and expansion into new markets. The company is focused on releasing additional imaging technologies designed for enhanced pediatric care by 2023. Furthermore, it aims to expand its presence in international markets, specifically targeting Europe and Asia by 2025, to increase the reach of its innovative imaging solutions.

## Funding rounds

- Series A, Apr 21, 2016, $3M — Wildermuth Endowment Strategy Fund

## Investors

- Wildermuth Endowment Strategy Fund (https://capitalatlas.ai/funds/wildermuth-endowment-strategy-fund) — Series A